Theophylline for Treatment of Pseudohypoparathyroidism
Theophylline for Treatment of Pseudohypoparathyroidism
Enrolling by invitation · NCT04240821 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Theophylline for Treatment of Pseudohypoparathyroidism | Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, bone disorder, calcium metabolic disease, hereditary disease, inborn errors of metabolism, inborn metal metabolism disorder, metabolic disease, musculoskeletal system disorder, pseudohypoparathyroidism, pseudohypoparathyroidism type 1A | Enrolling by invitation | Phase 2 | 2026-09-02 | NCT04240821 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jaclyn Tamaroff | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | United States | 71 |